A MERTK-Targeting Antibody–Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-25-2998
Affiliations:
3
Authors:
16
Go to article
Institutions Authors Share
Inspirna, Inc., United States of America (USA)
12.000000
12.000000
 0.75
The Rockefeller University, United States of America (USA)
3.000000
 0.19
L2P Research, United States of America (USA)
1.000000
 0.06
Interested in Oncology and Carcinogenesis?